Global Animal PCR Diagnostics Market to Reach US$ 411.3 Mn by 2034; Anticipated to Witness CAGR of 7.2% over the Forecast Period (2024 – 2034): A Report by TNR, The Niche Research

Increasing Demand for Early & Accurate Disease Detection in Both Companion Animals & Livestock is Accelerating the Animal PCR Diagnostics Market Demand


Wilmington, Delaware, July 02, 2024 (GLOBE NEWSWIRE) -- Animal PCR diagnostics refer to the use of Polymerase Chain Reaction (PCR) technology in veterinary medicine to detect and analyze genetic material (DNA or RNA) from animals. PCR diagnostics play a crucial role in identifying various diseases, pathogens, genetic disorders, and traits in both companion animals (pets) and livestock. This technology enables veterinarians to make timely and accurate diagnoses, monitor disease outbreaks, and assess the genetic health of animals. The global Animal PCR Diagnostics Market is experiencing robust growth driven by increasing pet ownership, rising demand for livestock health management, and advancements in PCR technology.

Visit our Homepage

Several trends are shaping the Animal PCR Diagnostics Market. One significant trend is the adoption of advanced PCR technologies such as quantitative real-time PCR (qPCR) and digital PCR (dPCR). These technologies offer higher sensitivity, specificity, and efficiency in detecting pathogens and genetic variations, thereby enhancing diagnostic accuracy. Another trend is the expansion of point-of-care testing capabilities in veterinary practices. There is a growing demand for rapid and on-site PCR diagnostics that provide quick results, facilitating immediate treatment decisions for companion animals and livestock. Opportunities in the market include the development of multiplex PCR assays capable of detecting multiple pathogens in a single test, thereby reducing testing time and costs. Additionally, the integration of PCR with other diagnostic technologies like next-generation sequencing (NGS) is opening new avenues for comprehensive genetic analysis in veterinary diagnostics.

Global Animal PCR Diagnostics Market: Key Datapoints

 

Market Value in 2023
 

US$ 191.5 Mn

 
 

Market Value Forecast by 2034
 

US$ 411.3 Mn

 
 

Growth Rate

 
 

7.2%
 

Historical Data

 
 

2016 – 2022
 

Base Year

 
 

2023
 

Forecast Data

 
 

2024 - 2034

The increasing prevalence of zoonotic diseases and infectious outbreaks among animals necessitates effective disease surveillance and management, boosting the demand for PCR diagnostics. Furthermore, the rising awareness of pet owners and livestock producers about preventive healthcare measures and genetic screening is fueling market growth. The expansion of veterinary healthcare infrastructure worldwide, coupled with investments in diagnostic capabilities, is also a significant growth driver. Governments and private organizations are increasingly focusing on improving animal health standards and food safety regulations, further propelling the adoption of PCR diagnostics in veterinary settings.

Get Sample Copy of the Report

The COVID-19 pandemic has had a mixed impact on the Animal PCR Diagnostics Market. While the initial phases of the pandemic led to disruptions in supply chains and reduced veterinary clinic visits, there was a subsequent increase in demand for PCR testing for pets and livestock. This surge was driven by heightened awareness of zoonotic transmission risks and the need for animal health monitoring. Moreover, the pandemic accelerated the adoption of telemedicine and remote diagnostic solutions in veterinary practices, which could continue to influence market dynamics post-pandemic. As veterinary clinics adapted to new operational norms, there was a notable shift towards digital PCR platforms and cloud-based diagnostic services, reflecting ongoing market adaptation and resilience. In conclusion, the Animal PCR Diagnostics Market is poised for significant growth driven by technological advancements, increasing pet ownership, and heightened awareness of animal health. Despite challenges posed by the pandemic, the market is adapting and expanding, offering promising opportunities for stakeholders investing in PCR technology and veterinary diagnostics.

Global Animal PCR Diagnostics Market: Key Takeaways:

  • Software and services segment is expected to grow at a CAGR of 5.4% in the animal PCR diagnostics market due to increasing adoption of PCR technology, driving demand for integrated software solutions to manage diagnostic data efficiently. Additionally, there is a rising need for specialized services such as training, maintenance, and consulting to support the implementation and operation of PCR systems in veterinary clinics and diagnostic laboratories.
  • Farm animal segment by animal type dominated the animal PCR diagnostics market with a substantial revenue share of 67.4% due to the large-scale adoption of PCR testing in livestock health management. PCR diagnostics enable rapid and accurate detection of infectious diseases and genetic traits essential for herd health and productivity. With increasing global demand for food products and stringent regulations on food safety, there's a heightened emphasis on effective disease surveillance and management in farm animals, driving market dominance in this segment.
  • Reverse transcription-quantitative PCR (RT-qPCR) segment in the animal PCR diagnostics market is anticipated to be the second largest with a revenue share of 22.9% in 2023 due to its versatility in quantifying RNA targets and its widespread application in viral load quantification and gene expression analysis in animals. This technology's ability to provide precise and sensitive measurements of RNA levels makes it invaluable for research and diagnostic purposes across various veterinary applications, contributing to its significant market presence.
  • Infectious disease testing by application dominated the animal PCR diagnostics market with a revenue share of 32.6% in 2023, due to the critical need for rapid and accurate detection of pathogens in both companion animals and livestock. PCR technology offers high sensitivity and specificity, enabling veterinarians to swiftly diagnose infectious diseases such as viral, bacterial, and fungal infections. This capability is crucial for effective disease management, treatment planning, and preventing outbreaks, driving its dominance in the market segment.
  • By end user, veterinary hospitals & clinics segment is anticipated to grow fastest over the forecast timeline due to increasing pet ownership and heightened awareness of animal health. These facilities are expanding their diagnostic capabilities with advanced PCR technologies to offer timely and accurate diagnoses for companion animals. The shift towards personalized pet care, coupled with rising demand for veterinary services, is driving investments in sophisticated diagnostic tools like PCR, enhancing growth prospects for this segment.
  • In 2023, North America dominated the global animal PCR diagnostics market due to its advanced healthcare infrastructure, high adoption rate of technological innovations in veterinary diagnostics, and robust spending on pet healthcare. The region's well-established veterinary healthcare system and stringent regulations promoting animal health and food safety drive the demand for PCR diagnostics. Additionally, increasing pet ownership rates and growing awareness of preventive veterinary care further bolster the market's growth in North America.

Browse Related Category Reports

Global Animal PCR Diagnostics Market Participants:

  • BIOMÉRIEUX
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Eurolyser Diagnostica GmbH
  • IDEXX Laboratories
  • INDICAL BIOSCIENCE GmbH
  • MEGACOR Diagnostik GmbH
  • Neogen Corporation
  • Thermo Fisher Scientific Inc. 
  • Zoetis
  • Other Industry Participants

Global Animal PCR Diagnostics Market

By Product Type

  • Reagents and Consumables
  • Instruments
  • Software and Services

By Animal Type

  • Farm Animals
    • Cattle
    • Poultry
    • Swine
    • Horses
    • Other Farm Animals
  • Companion Animals
    • Dogs
    • Cats
    • Others

By Technologies

  • Quantitative real-time PCR (qPCR)
  • Reverse transcription-PCR (RT-PCR)
  • Reverse transcription-quantitative PCR (RT-qPCR)
  • Digital PCR (dPCR) and digital droplet PCR (ddPCR)
  • Microfluidic PCR

By Application

  • Infectious Disease Testing
  • Genetic Testing
  • Cancer Diagnostics
  • Pathogen Surveillance
  • Others

By End User

  • Veterinary Diagnostic Centers
  • Veterinary Hospitals & Clinics
  • Research Institutions

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)  

Consult with Our Expert:

Jay Reynolds

The Niche Research

Japan (Toll-Free): +81 663-386-8111

South Korea (Toll-Free): +82-808- 703-126

Saudi Arabia (Toll-Free): +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

Email: askanexpert@thenicheresearch.com

Website: www.thenicheresearch.com